Structural basis of multi‐drug resistance by the Candida albicans ABC transporter CDR1
Protein Science · 2026-12 · 35 (12)
DOI: 10.1002/pro.70836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 16.11.2026. Verfasst von Jeeeun Shin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia. Hauptthemen laut MEDLINE: Candida albicans, Fungal Proteins, Membrane Transport Proteins, ATP-Binding Cassette Transporters. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Research Council (Centre of Excellence for Innovations in Peptide and Protein Science).
Abstract (Originalsprache)
The pleiotropic drug resistance transporter Candida drug resistance protein 1 (Cdr1) from Candida albicans is a major determinant of antifungal efflux‐mediated resistance. Here, we present cryo‐electron microscopy structures of C. albicans Cdr1 in multiple inward‐facing states, including a nucleotide‐loaded substrate‐free state, nucleotide‐loaded ternary complexes with rhodamine 6G or Oregon Green 488, and an lauryl maltose neopentyl glycol‐bound nucleotide‐free state. The 3.5 Å Cdr1‐adenosine triphosphate (ATP)/adenosine diphosphate (ADP) structure resolves asymmetric nucleotide occupancy, with ATP modeled at the degenerate nucleotide‐binding site 1 (NBS1) and ADP at the canonical nucleotide‐binding site 2, while the 3.4–3.5 Å ligand‐bound structures define overlapping binding modes within the pleiotropic transmembrane cavity. Molecular dynamics simulations indicate differential nucleotide stability at NBS1 and support dynamic ligand sampling within the transmembrane cavity. Evolutionary reconstruction and analysis of C. albicans sequence diversity further identify conserved mechanistic features and candidate residues for future functional testing. Together, these data extend the Cdr1 structural landscape beyond previously reported nucleotide‐free states and provide a focused framework for how asymmetric nucleotide handling and substrate recognition may be coupled in this clinically important fungal ABC transporter.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.
- Research School of Chemistry, Australian National University, Canberra, Australian Capital Territory, Australia.
- Centre for Advanced Microscopy, Australian National University, Canberra, Australian Capital Territory, Australia.
ORCID-Profile: Jeeeun Shin, Chacko Jobichen, Colin Jackson, Melanie Rug, Ben Corry, Joseph Brock
Förderung
- Australian Research Council (Centre of Excellence for Innovations in Peptide and Protein Science)
Zitieren
APA
Shin, J., Jin, R., Gall, B., Jobichen, C., Jackson, C., Rug, M., Corry, B., & Brock, J. (2026). Structural basis of multi‐drug resistance by the Candida albicans ABC transporter CDR1. Protein Science, 35(12). https://doi.org/10.1002/pro.70836
Vancouver
Shin J, Jin R, Gall B, Jobichen C, Jackson C, Rug M, et al. Structural basis of multi‐drug resistance by the Candida albicans ABC transporter CDR1. Protein Science. 2026;35(12). doi:10.1002/pro.70836
BibTeX
@article{Shin2026,
author = {Shin, Jeeeun and Jin, Ruitao and Gall, Barnabas and Jobichen, Chacko and Jackson, Colin and Rug, Melanie and Corry, Ben and Brock, Joseph},
title = {Structural basis of multi‐drug resistance by the Candida albicans ABC transporter CDR1},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {12},
doi = {10.1002/pro.70836}
}
EUVIMED